Praxis Precision Medicines, Inc.
PRAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $8,553 | $2,447 | $0 | $0 |
| % Growth | 249.5% | – | – | – |
| Cost of Goods Sold | $152,413 | $86,766 | $154,440 | $0 |
| Gross Profit | -$143,860 | -$84,319 | -$154,440 | $0 |
| % Margin | -1,682% | -3,445.8% | – | – |
| R&D Expenses | $152,413 | $86,766 | $155,040 | $120,257 |
| G&A Expenses | $56,305 | $42,054 | $59,546 | $47,075 |
| SG&A Expenses | $56,305 | $42,054 | $59,546 | $47,075 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$152,413 | -$86,766 | -$154,040 | $0 |
| Operating Expenses | $56,305 | $42,054 | $60,546 | $167,332 |
| Operating Income | -$200,165 | -$126,373 | -$214,986 | -$167,332 |
| % Margin | -2,340.3% | -5,164.4% | – | – |
| Other Income/Exp. Net | $17,346 | $3,096 | $957 | $271 |
| Pre-Tax Income | -$182,819 | -$123,277 | -$214,029 | -$167,061 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$182,819 | -$123,277 | -$214,029 | -$167,061 |
| % Margin | -2,137.5% | -5,037.9% | – | – |
| EPS | -10.21 | -18.69 | -69.33 | -58.96 |
| % Growth | 45.4% | 73% | -17.6% | – |
| EPS Diluted | -10.21 | -18.69 | -69.33 | -58.96 |
| Weighted Avg Shares Out | 17,907 | 6,594 | 3,073 | 2,830 |
| Weighted Avg Shares Out Dil | 17,907 | 6,594 | 3,073 | 2,830 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17,346 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $358 | $432 | $419 | $182 |
| EBITDA | -$199,807 | -$125,941 | -$213,567 | -$167,150 |
| % Margin | -2,336.1% | -5,146.8% | – | – |